Australia Pharmaceutical Pricing & Reimbursement Concise Guide 2017 - Research and Markets

DUBLIN--()--The "IMS Pharmaceutical Pricing & Reimbursement Concise Guide: Australia" report has been added to Research and Markets' offering.

The Pharmaceutical Pricing & Reimbursement Concise Guides are established as the definitive reference and training text for P&R professionals around the world, drawing on the long-standing expertise of the IMS pricing and reimbursement specialists to provide industry players and decision makers with a thorough understanding of the rules and regulations governing P&R in international markets.

This report covers key developments in P&R, market access, cost containment, trade margins and healthcare issues.

Key Topics Covered:

1. Healthcare System

  • Facts & Figures
  • Market Indicators
  • Provision & Funding
  • Private Insurance
  • Healthcare Services

2. Pricing

  • Prescription Drugs
  • Pricing Procedure
  • Pricing Mechanisms
  • Background
  • Generic Drugs
  • Hospital Drugs
  • OTC Drugs

3. Reimbursement

  • Admission to Reimbursement
  • Application Process
  • Listing Recommendations
  • PBAC Reform
  • Formularies
  • Reimbursement Restrictions
  • Reimbursement Categories
  • Reimbursement Prices
  • Hospital Reimbursement
  • Formularies
  • Funding
  • Changes in Reimbursement Status
  • Minor Submissions
  • Major Submissions
  • Other Changes
  • Post-market Reviews
  • Delisting of OTCs
  • Changes in Reimbursement Prices
  • Price Adjustments
  • Price Reviews
  • Price Cuts
  • Price Disclosure

4. Pharmacoeconomics

  • Pharmacoeconomic Requirements
  • Pharmaceutical Benefits Scheme
  • Hospital Formularies

5. Price Build Up

  • Wholesalers
  • Mark-ups
  • CSO Funding Pool
  • Background
  • Retail Pharmacies
  • Margins
  • Background
  • Dispensing Doctors
  • Sales Tax

6. Cost Containment

  • Industry Paybacks
  • Promotional Costs
  • Expenditure
  • Controls over Advertising and Promotion
  • Patient Co-payments
  • Healthcare
  • Prescribing Controls
  • National Prescribing Service
  • Hospital Prescribing
  • Reimbursement Restrictions
  • E-Health
  • Generics
  • Substitution
  • Sustainability Initiative
  • INN Prescribing
  • Rx-to-OTC Switches
  • Procedure for Switching
  • Recent Switches
  • Other Changes of Status
  • OTC Market
  • Parallel Trade

7. Future Developments

  • Outlook
  • Healthcare System
  • PBS Medicine Package 2017
  • Wholesalers and Retail Pharmacies
  • Review of Pharmacy Remuneration and Location
  • Advertising of Schedule 3 Medicines

8. Names & Addresses

For more information about this report visit https://www.researchandmarkets.com/research/zpz5dd/ims

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Pharmaceuticals, Pharmacoeconomics

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Pharmaceuticals, Pharmacoeconomics